Device / Technology News

RSS

Clinical evaluation of benzodiazepine products is now allowed using Acura's Aversion Technology

Acura Pharmaceuticals, Inc. today announced clinical evaluation is now allowed under an Investigational New Drug application ("IND") filed with the U.S. Food and Drug Administration ("FDA") for a benzodiazepine product candidate utilizing our Aversion® Technology.

16 Mar 2010

Tel Aviv University researcher uses magic tricks to treat children with locomotor disabilities

It's often hard to motivate youngsters with physical disabilities. But a new approach from a Tel Aviv University researcher bridges the worlds of behavior and science to help kids with paralysis and motor dysfunction improve their physical skills and inner confidence -- using a trick up her sleeve called "magic."

16 Mar 2010

Elmora Healthcare selects Authentidate's Inscrybe Healthcare for expediting care order processing

Authentidate Holding Corp., a worldwide provider of secure Health Information Exchange, workflow management services and telehealth solutions, today announced that Elmora Healthcare, a supplier of home medical equipment, medical supplies and care services, selected Authentidate's Inscrybe® Healthcare web-based service to expedite processing of patient care orders with referring physicians.

16 Mar 2010

Nuvo Research commences enrollment in WF10 Phase 2 clinical trial for allergic rhinitis

Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced that it has enrolled the first patient in its European Phase 2 clinical trial evaluating WF10 as a treatment for allergic rhinitis.

16 Mar 2010

Aegis Health Group releases PRISM software to help hospital leaders improve physician relationships

Aegis Health Group, the nation's leading healthcare business development company, announces new software to help hospital leaders improve physician relationships, track referral patterns, better manage physician issues, and gain market intelligence. PRISM™, Aegis' proprietary physician relationship management software, is a browser-based database and contact-management program that can be customized to fit the unique needs of each hospital.

16 Mar 2010

Forensic Laboratories introduces first oral fluid test for Tapentadol

Forensic Laboratories, a Denver-based laboratory specializing in toxicology services for drug abuse, has unveiled the first oral fluid test for Tapentadol, a new federally approved drug prescribed by doctors for pain management. Previously, laboratories could only detect the drug through urine using liquid chromatography-mass spectrometry-mass spectrometry (LC/MS/MS) technology.

15 Mar 2010

Cook Medical launches new NavAlign femoral delivery system at SIR Annual Scientific Meeting

Physicians placing inferior vena cava (IVC) filters to prevent life-threatening pulmonary emboli now have access to the latest iteration of Cook Medical’s advanced NavAlign™ delivery system, a deployment system designed to minimize the risk of vessel trauma and streamline filter placement.

15 Mar 2010

Boston Scientific stops shipment and announces inventory retrieval of ICDs and CRT-Ds

Boston Scientific Corporation announced today that it has stopped shipment and is retrieving field inventory of all its implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds).

15 Mar 2010

Comparison study of genetic tests for ASD finds CMA with highest detection rate

The Autism Consortium, an innovative research, clinical and family collaboration dedicated to catalyzing research and enhancing clinical care for families with autism spectrum disorders (ASDs), announced today that the results of its comparison study of genetic testing methods for autism spectrum disorders is available from the journal Pediatrics through early online release in their eFirst pages today and will appear in the journal's April issue.

15 Mar 2010

FDA questions third-party review of medical devices

The Wall Street Journal: The FDA is considering ending a program that allows medical-equipment makers to have their products reviewed by third-party companies instead of by FDA officials.

15 Mar 2010

High ABI may indicate risk for future heart attacks

The prevalence of abnormal ankle-brachial index (ABI) test results among individuals tested for peripheral arterial disease (PAD)—and who are not considered at high risk of a coronary heart event by Framingham-based risk factors—is high and provides another way to identify those who may be at risk for future heart attacks, say researchers at the Society of Interventional Radiology's 35th Annual Scientific Meeting in Tampa, Fla.

15 Mar 2010

Medtronic announces positive STOP AF clinical trial data at 59th American College of Cardiology session

Medtronic, Inc. today announced data from the STOP AF (Sustained Treatment of Paroxysmal Atrial Fibrillation) clinical trial during late-breaking sessions at the 59th Annual Scientific Session of the American College of Cardiology in Atlanta. The data showed superiority over anti-arrhythmic drugs, with 69.9 percent of patients with paroxysmal atrial fibrillation (PAF) treated with the Arctic Front® Cardiac CryoAblation Catheter System remaining free of atrial fibrillation (AF) one year after cryoablation, compared to 7.3 percent on drug therapy.

15 Mar 2010

Stimulus funds spur Indiana doctors, hospitals to switch to electronic records more quickly

The offer of federal stimulus funds is spurring Indiana health care providers to convert to electronic medical records, The (Fort Wayne, Ind.) Journal Gazette reports.

15 Mar 2010

Enzo Biochem to market MultiGEN’s multiplex DNA sequencing based diagnostic tests in state of New York

Enzo Biochem, Inc. today announced that it has entered into an agreement with MultiGEN Diagnostics Inc., of San Diego, California, for exclusive rights to market MultiGEN’s unique diagnostic tests based on multiplex DNA sequencing, in the state of New York. In addition, Enzo has been granted marketing rights for other non-exclusive territories in United States.

15 Mar 2010

St. Jude Medical announces updates to PressureWire platform at ACC and SIR annual meetings

St. Jude Medical, Inc., a global medical device company, announced several updates to its PressureWire™ platform, including a new marketing agreement with Siemens Medical Solutions USA, for the wireless PressureWire™ Aeris and the availability of the next-generation of PressureWire™ Certus technology, at the American College of Cardiology and the Society of Interventional Radiology annual meetings.

15 Mar 2010

Positive results from second phase of ABSORB clinical trial on BVS technology

Abbott today announced positive 30-day results from the first 101 patients enrolled in the second phase of the ABSORB trial. Patients treated with Abbott's bioresorbable vascular scaffold (BVS), under clinical investigation in Europe, demonstrated no cases of blood clots (thrombosis), no need for repeat procedures (ischemia-driven target lesion revascularization) and a very low rate of major adverse cardiac events (MACE(1) rate of 2.0 percent) at 30 days.

15 Mar 2010

iGPS urges the U.S. Senate to mandate latest tracking technology in legislation to prevent foodborne illnesses

Cost-effective technology that allows products to be traced through the U.S. supply chain might have helped contain the spread of hydrolyzed vegetable protein products contaminated with Salmonella, Intelligent Global Pooling Systems announced today. iGPS urged the U.S. Senate to mandate the latest tracking technology in legislation pending to overhaul the nation's food safety law.

15 Mar 2010

Reducing collateral damage to excised tissue: Surgeons study device using radiofrequency energy

Every year more than 100,000 women in the United States undergo a lumpectomy, a conservative procedure to remove cancerous tumors while preserving the breast. The surgeon's goal is to attain a tumor-free, or negative, surgical margin the first time they operate. Current surgical tools may cause heat damage to the tissue samples needed for examination by a pathologist in order to identify the presence of cancerous cells on the edges of tumors.

15 Mar 2010

Presence of plaque on abdominal CT scan: Strong predictor of coronary artery disease and mortality

The presence of plaque on an abdominal CT scan is a strong predictor of coronary artery disease and mortality, according to a Henry Ford Hospital study.

15 Mar 2010

NDSsi launches ZeroWire Full HD video solution for minimally-invasive surgery

NDS Surgical Imaging today announced the launch of ZeroWire®, a medical-grade wireless Full HD video solution for minimally-invasive surgery, GI and interventional suites. Customers in the European Union will be offered this high-technology video solution which is customized to meet the video transmission challenges of the operating room. NDSsi has plans to also launch its ZeroWire solution in the United States and Asia-Pacific regions in the coming months.

15 Mar 2010

Device / Technology News

Clinical evaluation of benzodiazepine products is now allowed using Acura's Aversion Technology

Tel Aviv University researcher uses magic tricks to treat children with locomotor disabilities

Elmora Healthcare selects Authentidate's Inscrybe Healthcare for expediting care order processing

Nuvo Research commences enrollment in WF10 Phase 2 clinical trial for allergic rhinitis

Aegis Health Group releases PRISM software to help hospital leaders improve physician relationships

Forensic Laboratories introduces first oral fluid test for Tapentadol

Cook Medical launches new NavAlign femoral delivery system at SIR Annual Scientific Meeting

Boston Scientific stops shipment and announces inventory retrieval of ICDs and CRT-Ds

Comparison study of genetic tests for ASD finds CMA with highest detection rate

FDA questions third-party review of medical devices

High ABI may indicate risk for future heart attacks

Medtronic announces positive STOP AF clinical trial data at 59th American College of Cardiology session

Stimulus funds spur Indiana doctors, hospitals to switch to electronic records more quickly

Enzo Biochem to market MultiGEN’s multiplex DNA sequencing based diagnostic tests in state of New York

St. Jude Medical announces updates to PressureWire platform at ACC and SIR annual meetings

Positive results from second phase of ABSORB clinical trial on BVS technology

iGPS urges the U.S. Senate to mandate latest tracking technology in legislation to prevent foodborne illnesses

Reducing collateral damage to excised tissue: Surgeons study device using radiofrequency energy

Presence of plaque on abdominal CT scan: Strong predictor of coronary artery disease and mortality

NDSsi launches ZeroWire Full HD video solution for minimally-invasive surgery

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News